RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders
Authors:
- Nãºria Martãn-FloresNMNãºria Martãn-Flores
- VãcTor Pã©Rez-Fernã¡NdezVPVãcTor Pã©Rez-Fernã¡Ndez
- Cristina MalageladaCMCristina Malagelada
Open Access
- 2 October 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 8, 313
Abstract
MTOR (mechanistic target of Rapamycin) pathway regulates essential processes directed to preserve cellular homeostasis, such as cell growth, proliferation, survival, protein synthesis and autophagy. Importantly, mTOR pathway deregulation has been related to many diseases. Indeed, it has become a hallmark in neurodegenerative disorders, since a fine-tuned regulation of mTOR activities is crucial for neuron function and survival. RTP801/REDD1/Dig2 has become one of the most puzzling regulators of mTOR. Although the mechanism is not completely understood, RTP801 inactivates mTOR and Akt via the tuberous sclerosis complex (TSC1/TSC2) in many cellular contexts. Intriguingly, RTP801 protects dividing cells from hypoxia or H2O2-induced apoptosis, while it sensitizes differentiated cells to stress. Based on experimental models of PD, it has been proposed that at early stages of the disease, stress-induced RTP801 upregulation contributes to mTOR repression, in an attempt to maintain cell function and viability. However, if RTP801 elevation is sustained, it leads to neuron cell death by a sequential inhibition of mTOR and Akt. Here, we will review RTP801 deregulation of mTOR in a context of PD and other neurodegenerative disorders.Keywords
This publication has 73 references indexed in Scilit:
- Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approachToxicology Letters, 2014
- RTP801 Regulates Maneb‐ and Mancozeb‐Induced Cytotoxicity via NF‐κBJournal of Biochemical and Molecular Toxicology, 2014
- Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease modelsBrain Research, 2014
- FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease modelsNeuroscience, 2012
- The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative DiseasesToxicological Sciences, 2011
- Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningJournal of Cell Biology, 2006
- The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin PathwayJournal of Biological Chemistry, 2005
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complexGenes & Development, 2004
- Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient MiceInvestigative Ophthalmology & Visual Science, 2004
- Time-restricted role for dendritic activation of the mTOR-p70 S6K pathway in the induction of late-phase long-term potentiation in the CA1Proceedings of the National Academy of Sciences, 2003